A bill to require the Administrator of the Centers for Medicare & Medicaid Services to submit a report regarding the use of coverage and reimbursement authorities to protect the markets for active pharmaceutical ingredients and key staring materials.

Based on the bill's title, this bill would require the Centers for Medicare & Medicaid Services (CMS) Administrator to submit a report to Congress examining how CMS's coverage and reimbursement authorities could be used to protect domestic markets for active pharmaceutical ingredients and key starting materials. The bill appears focused on understanding potential policy tools rather than implementing new requirements directly.

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.